BRIEF published on 10/23/2025 at 13:21, 10 months 9 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
PRESS RELEASE published on 10/23/2025 at 13:16, 10 months 9 days ago Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025 Biotest AG cancels extraordinary general meeting scheduled for 28 October 2025 following withdrawal of convocation request by Grifols S.A Grifols S.A. Cancellation Extraordinary General Meeting Biotest AG Legal Form Change
BRIEF published on 10/09/2025 at 17:35, 10 months 23 days ago Yimmugo® de Biotest entre sur le marché américain Biotest AG Marché Américain Lancement De Yimmugo® Déficits Immunitaires Primaires Médicaments Dérivés Du Plasma
BRIEF published on 10/09/2025 at 17:35, 10 months 23 days ago Biotest's Yimmugo® Enters the U.S. Market Biotest AG U.S. Market Yimmugo® Launch Primary Immunodeficiencies Plasma-derived Medicines
PRESS RELEASE published on 10/09/2025 at 17:30, 10 months 23 days ago Biotest’s Yimmugo® launches in the United States Biotest AG launches Yimmugo®, a polyvalent human normal immunoglobulin (IVIg) for primary immunodeficiencies in the U.S., marking a significant milestone for the company's global growth strategy Biotest AG Yimmugo U.S. Launch Primary Immunodeficiencies IVIg
BRIEF published on 09/19/2025 at 15:05, 11 months 12 days ago Biotest AG Schedules Extraordinary General Meeting for Legal Form Change Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 09/19/2025 at 15:05, 11 months 12 days ago Biotest AG organise une assemblée générale extraordinaire pour modifier sa forme juridique Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
PRESS RELEASE published on 09/19/2025 at 15:00, 11 months 12 days ago Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG's extraordinary general meeting convened at the request of Grifols S.A. to discuss changing legal form to a partnership limited by shares (KGaA) on 28 October 2025 Extraordinary General Meeting Biotest AG Legal Form Change Grifols Partnership Limited By Shares
BRIEF published on 08/04/2025 at 13:05, 1 year ago Biotest AG fait l'objet d'un examen pour un changement de structure juridique Grifols SA Biotest AG Droits Des Actionnaires Structure Juridique Réunion Extraordinaire
BRIEF published on 08/04/2025 at 13:05, 1 year ago Biotest AG Under Review for Legal Structure Change Grifols S.A. Shareholder Rights Biotest AG Extraordinary Meeting Legal Structure
Published on 09/01/2026 at 23:05, 11 hours 8 minutes ago Aton Announces US$30M Credit Facility with OU Moonrider
Published on 09/01/2026 at 22:30, 11 hours 43 minutes ago Algo Grande Copper Closes Oversubscribed Private Placement for $4.786 Million
Published on 09/01/2026 at 22:15, 11 hours 58 minutes ago NuRAN Wireless Announces Plans to Voluntarily Delist from the Canadian Securities Exchange
Published on 09/01/2026 at 16:10, 18 hours 3 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/02/2026 at 10:05, 8 minutes ago Thunes Champions Ethical Global Payments with its 2026 United Nations Global Compact Commitment
Published on 09/02/2026 at 10:05, 8 minutes ago PANASONIC PIONEERS GLOBAL SHUTTER TECHNOLOGY WITH AW-UE200 & AW-UER200 PTZ SERIES
Published on 09/02/2026 at 10:05, 8 minutes ago CIGRE 2026: Building power grids for a new age of electrification
Published on 09/02/2026 at 10:05, 8 minutes ago BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser
Published on 09/02/2026 at 07:43, 2 hours 29 minutes ago Accor launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2032 for a nominal amount of €380 million and a concurrent partial repurchase offer with respect to its outstanding OCEANEs due 2027 by
Published on 09/02/2026 at 07:43, 2 hours 29 minutes ago Accor lance une émission d’obligations à option de conversion en actions nouvelles et/ou d’échange en actions existantes (OCEANEs) à échéance 2032 pour un montant nominal de 380 millions d’euros et une offre concomitante de rachat partiel de s
Published on 09/01/2026 at 19:00, 15 hours 13 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 19:00, 15 hours 13 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 09/01/2026 at 18:18, 15 hours 55 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Août 2026
